US Stock MarketDetailed Quotes
VTVT vTv Therapeutics
- 14.9600
- +0.4400+3.03%
Close Dec 20 16:00 ET
39.08MMarket Cap-3.42P/E (TTM)
15.1000High14.8200Low5.18KVolume14.8244Open14.5200Pre Close77.06KTurnover0.49%Turnover RatioLossP/E (Static)2.61MShares30.990052wk High2.60P/B15.90MFloat Cap7.380052wk Low--Dividend TTM1.06MShs Float560.0000Historical High--Div YieldTTM1.93%Amplitude7.3800Historical Low14.8680Avg Price1Lot Size
About vTv Therapeutics Company
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
Company Profile
SymbolVTVT
Company NamevTv Therapeutics
Listing DateJul 30, 2015
Issue Price15.00
Founded2015
CEOMr. Paul J. Sekhri
MarketNASDAQ
Employees16
Fiscal Year Ends12-31
Address3980 Premier Drive,Suite 310
CityHigh Point
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27265
Phone1-336-841-0300
Company Executives
- Name
- Position
- Salary
- Paul J. Sekhri
- Chairman of the Board, President and Chief Executive Officer
- 650.91K
- Steven L. Tuch
- Executive Vice President and Chief Financial Officer
- 465.25K
- Richard S. Nelson
- Director and Executive Vice President, Corporate Development
- --
- Dr. Jonathan Isaacsohn
- Executive Chairman of the Board
- --
- Dr. Raymond Cheong, PhD
- Director
- --
- Dr. Srinivas Akkaraju
- Director
- --
- Daniel K. Spiegelman
- Director
- --
- Hersh Kozlov
- Director
- 100.13K
- Dr. Anne M. Phillips, M.D.
- Independent Director
- --
- Fahed Al-Marzooqi
- Independent Director
- 87.63K
- Dr. Keith Harris
- Independent Director
- 107.63K
Heat List
US
Overall
Symbol
Price
% Chg
No Data